PortfoliosLab logo
Cassava Sciences Inc. Warrant (SAVAW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

Jan 4, 2024

Highlights

Year Range

$0.03 - $0.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cassava Sciences Inc. Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


SAVAW (Cassava Sciences Inc. Warrant)
Benchmark (^GSPC)

Returns By Period


SAVAW

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.93%

1M

11.36%

6M

-1.09%

1Y

10.19%

5Y*

14.74%

10Y*

10.35%

*Annualized

Monthly Returns

The table below presents the monthly returns of SAVAW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024119.24%-23.02%-24.67%-94.21%-87.15%0.00%0.00%0.00%0.00%-99.05%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SAVAW is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SAVAW is 1515
Overall Rank
The Sharpe Ratio Rank of SAVAW is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of SAVAW is 33
Sortino Ratio Rank
The Omega Ratio Rank of SAVAW is 00
Omega Ratio Rank
The Calmar Ratio Rank of SAVAW is 4747
Calmar Ratio Rank
The Martin Ratio Rank of SAVAW is 99
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cassava Sciences Inc. Warrant (SAVAW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There is not enough data available to calculate the Sharpe ratio for Cassava Sciences Inc. Warrant. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
SAVAW (Cassava Sciences Inc. Warrant)
Benchmark (^GSPC)

Dividends

Dividend History

Cassava Sciences Inc. Warrant provided a 3.33% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


PeriodTTM
Dividend$0.00

Dividend yield

3.33%

Monthly Dividends

The table displays the monthly dividend distributions for Cassava Sciences Inc. Warrant. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


SAVAW (Cassava Sciences Inc. Warrant)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cassava Sciences Inc. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cassava Sciences Inc. Warrant was 99.68%, occurring on May 2, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.68%Jan 18, 202474May 2, 2024
-0.95%Jan 5, 20241Jan 5, 20241Jan 8, 20242
-0.56%Jan 16, 20241Jan 16, 20241Jan 17, 20242

Volatility

Volatility Chart

The current Cassava Sciences Inc. Warrant volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


SAVAW (Cassava Sciences Inc. Warrant)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cassava Sciences Inc. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Cassava Sciences Inc. Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio
20.040.060.080.0100.0
SAVAW: 0.0
This chart shows the Price-to-Sales (P/S) ratio for SAVAW relative to other companies in the Biotechnology industry. Currently, SAVAW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
2.04.06.08.010.0
SAVAW: 0.0
The chart illustrates the Price-to-Book (P/B) ratio for SAVAW in comparison with other companies in the Biotechnology industry. Currently, SAVAW has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items